Peripheral chemoreflex sensitivity is potentiated in both clinical and experimental chronic heart failure (CHF). Downregulation of nitric oxide (NO) synthase in the carotid body (CB) is involved in this effect. However, it remains poorly understood whether carbon monoxide (CO) also contributes to the altered peripheral chemoreflex sensitivity in CHF. This work highlights the effect of NO and CO on renal sympathetic nerve activity (RSNA) in response to graded hypoxia in conscious rabbits. RSNA responses to graded hypoxia were enhanced in CHF rabbits compared with that in sham rabbits. Both the NO donor (S-nitroso-N-acetylpenicillamine, SNAP, inhibitor (Cr (III) mesoporphyrin IX chloride, CrMP, 0.5 mg/kg) augmented the RSNA response to hypoxia in sham rabbits to a greater extent than either inhibitor alone, and was without effect in CHF rabbits. In addition, using immunostaining and western blot analyses, we found expression of neural NOS (0.19±0.04, the ratio with E-tubulin protein), endothelial NOS (0.17±0.06), and HO-2 (0.15±0.02) protein in CBs from CHF lower than that (0.63±0.04, 0.56±0.06 and 0.27±0.03, respectively, p<0.05) from sham rabbits. These results suggest that a deficiency of both NO and CO in the CBs augments peripheral chemoreflex sensitivity to hypoxia in CHF.
INTRODUCTION
Enhanced peripheral chemoreflex sensitivity occurs in patients with chronic heart failure (CHF) and in experimental models of CHF(4; 5; 12; 16; 17; 24; 28) . Arterial chemoreceptors in the aortic and carotid bodies (CB) are the principle sensory receptors that detect changes in arterial oxygen (6; 8; 18). Our previous studies have documented that an augmented afferent input from the CB chemoreceptors is involved in the enhancement of peripheral chemoreflex function in pacing-induced CHF rabbits (28) , and this enhanced sensitivity of the peripheral chemoreflex contributes to the sympathetic activation in the CHF state (27) . However, the mechanism of CB hypersensitivity induced-sympathetic activation in CHF is not well resolved.
Several lines of evidence indicate the endogenous production of nitric oxide (NO) plays
an important role in modulating CB chemoreceptor activity to hypoxia. Previous work from our laboratory demonstrated that a decreased NO production in the CB was involved in the enhanced chemoreceptor activity in CHF (10; 27). Neural nitric oxide synthase (nNOS) is downregulated in the CB in CHF (10) and administration of a NO donor reduces the elevated CB chemoreceptor discharge in CHF rabbits (27) . Gene transfer of nNOS to CBs reverses the enhanced chemoreceptor function in CHF rabbit (10). Endogenously generated carbon monoxide (CO) from heme oxygenases-2 (HO-2) is also a physiological regulator of CB activity (1; 19; 35) . However, it is not known whether CO is also involved in the peripheral chemoreflex hypersensitivity in the experimental CHF rabbit.
In the present study, we first measured renal sympathetic nerve activity (RSNA) in response to graded hypoxia before and after intravenous administration of a CO donor, tricarbonyldichlororuthenium (II) dimmer, ([Ru(CO) 3 Cl 2 ] 2 ); HO inhibitor, Cr (III) mesoporphyrin IX chloride (CrMP); NO donor, S-nitroso-N-acetylpenicillamine (SNAP); or NOS inhibitor, N A -nitro-L-arginine (LNNA) in sham and CHF rabbits. Secondly, we observed the effects on chemoreflex function after the combined NO/CO manipulation. Thirdly, we investigated protein expression of both NOS and HO-2 in the CBs from sham and CHF rabbits in order to determine whether the enhanced peripheral chemoreflex function in CHF rabbits is concomitant with an altered expression of NOS and HO-2 in the CB from these animals.
MATERIALS AND METHODS

Experimental animals:
All experiments were carried out on 56 male New Zealand White rabbits weighing 2.5-3.5 kg. The experimental protocols were approved by the University of Nebraska Medical Center Institutional Animal Care and Use Committee and were carried out in accordance with the National Institutes of Health (NIH Publication No. 85-23, revised 1996) and the American Physiological Society's Guides for the Care and Use of Laboratory Animals.
Rabbits were housed in individual cages under controlled temperature and humidity and a 12:12 h dark:light cycle, and fed standard rabbit chow with water available ad libitum. They were assigned to sham-operated and CHF groups.
Pacemaker implant and induction of CHF:
Rabbits were anesthetized with a cocktail consisting of 1.2 mg acepromazine, 5.9 mg xylazine and 58.8 mg ketamine, given as an i.m.
injection. Using sterile technique, a left thoracotomy was performed as previously described (10; 12; 28). Briefly, a pin electrode was attached to the left ventricle for pacing. The chest was closed. Rabbits were placed on an antibiotic regimen consisting of 5 mg/kg Baytril i.m. for 5 days. After the rabbits recovered from the thoracotomy (about 2 weeks), the pacing was started at 320 bpm, which was held for 7 days, and then the rate was gradually increased to 360 bpm, with an increment of 20 bpm each week. The progression of CHF was monitored by weekly echocardiograms (Acuson Sequoia 512C with a 4 MHz probe) with the pacemaker turned off for at least 30 min before the recordings were started. Sham-operated animals underwent a similar period of echocardiographic measurements. CHF was characterized by a > 40% reduction in ejection fraction and fraction of shortening, and dilation of the left ventricle in both systole and diastole.
Recording of renal sympathetic nerve activity (RSNA): RSNA recording electrodes were implanted as described previously (10; 12; 28). At the same time, arterial/venous catheters were inserted into the right carotid artery and jugular vein. The experiments were carried 3-5 days after surgery. Changes of RSNA in response to stimulation of peripheral chemoreceptors were recorded in sham and CHF rabbits in the conscious state according to our previous method (10; 12; 28). RSNA was expressed as % maximum, and maximal RSNA was determined in each rabbit by an intravenous bolus injection of sodium nitroprusside (100 µg/kg) (13). Peripheral chemoreceptors were stimulated preferentially by allowing the rabbits to breathe graded mixtures of hypoxic gas 3 min under isocapnic conditions. Because hypoxic stimulation of ventilation induces hyperventilatory hypocapnia, 2-4% CO 2 was added to the hypoxic gases to maintain relatively constant PaCO 2 during hyperventilation (28) .
Experimental Protocols for RSNA recording: After the pacemaker was turned off for approximately 30 min, the mean arterial pressure (MAP), heart rate (HR) and RSNA were measured at normoxia (21% O 2 ) and different levels of hypoxia (15% and 10% O 2 ). The PaO 2 and PaCO 2 and pH of arterial blood were measured by using a blood-gas analyzer (ABL5, Radiometer, Copenhagen, Denmark)). To investigate the effects of endogenous CO and NO on RSNA in response to hypoxia in sham and CHF rabbits, the protocols were assigned as follows:
Protocol 1: Effects of HO inhibitor CrMP
In sham and CHF rabbits, the RSNA-PaO 2 curve was recorded before and after administration of HO inhibitor CrMP (0.5 mg/kg bolus intravenous injection). Similarly, intravenous infusion of hydralazine was used to minimize activation of the baroreflex. The other procedures were followed as in protocol 4. Doses of drugs used in this study were based on established effective dosages (14; 15; 27; 29; 32) and the dose-response curves in our preliminary study. All drugs were freshly prepared before perfusion on the experimental day.
Immunofluorescence detection: The animals were perfused transcardially with 4% paraformaldehyde for 30 min. Both CBs in each rabbit and rapidly removed and postfixed in 4% paraformaldehyde for 12 h at 4 °C, followed by soaking the CBs in 30% sucrose for 12 h at 4 °C for cryostat protection. The CB was cut into 10 <m-thick sections. The CB sections were mounted on precoated glass slides for immunofluorescence for nNOS, endothelial NOS (eNOS), HO-2 and tyrosine hydroxylase (TH) detection. CB sections on the glass slide were incubated with 10% normal donkey or goat serum for 1 h followed by incubation with primary anti-nNOS, anti-eNOS, anti-HO-2 and anti-TH antibodies overnight at 4 °C. Then the sections were incubated with appropriate secondary antibody for 60 min at room temperature. Slides were observed under a Leica fluorescent microscope with appropriate excitation/emission filters.
Pictures were captured by a digital camera system. No staining was observed when the procedure described above was repeated using PBS instead of the primary antibody.
Western Blot analysis for rabbit NOS and HO-2: CBs were rapidly removed and immediately frozen in dry ice and stored at -80 °C until analyzed. In brief, the protein in CBs was extracted in lysing buffer (10 mM PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 1% SDS) plus protease inhibitor cocktail (100 µl/ml). Following a centrifugation at 12,000 g for 20 min at 4 ዊC, protein concentration in the supernatant was measured using a BCA protein assay kit (Pierce Chemical, Rockford, IL, USA). Samples were adjusted to the same concentrations of protein with equal volumes of loading buffer containing ß-mercaptoethanol and boiled for 5 min. 
Data analysis:
All values are presented as means ± SE. RSNA was expressed as percent of the maximal nerve activity as described in the METHODS. Peripheral chemoreflex function curves were analyzed by plotting data points averaged over 30 s for RSNA against the corresponding PaO 2 . Statistical significance was determined by student's paired t test for hemodynamics, and student's unpaired t test for protein expression between sham and CHF rabbits. A two-way ANOVA, with a Bonferroni procedure for post hoc analysis was used in comparisons of the changes of RSNA in response to graded levels of hypoxia. All data were confirmed to fit reasonably within normal distribution, and equality of variances was confirmed by the Levene test. Statistical significance was accepted when P < 0.05.
RESULTS:
Characteristics of the CHF State CHF was induced by the 3rd or 4th week of rapid ventricular pacing, consistent with our previous studies (10; 12; 28). CHF was characterized by an enlarged heart and weak contractile function as evaluated by the changes of heart weight, LV chamber diameter, and the shortening and ejection fractions ( Table 1 ). The paced rabbits also exhibited a slight decrease in MBP and a significant increase in HR than that in the unpaced state.
Effect of HO inhibitor, CO donor, NOS inhibitor and NO donor on baseline MAP, HR and RSNA
Intravenous injection of HO inhibitor CrMP (0.5 mg/kg) induced a transient slight MBP increase of 5-8 mm Hg in sham and CHF rabbits that returned to control levels. HR was not significant different from baseline levels in sham and CHF rabbits. Baseline RSNA was increased in sham rabbits and not changed in CHF rabbits ( Table 2 ). The infusion of CO donor [Ru(CO) 3 Cl 2 ] 2 (3.0 <g/kg/min) did not alter baseline MAP and HR in sham and CHF rabbits.
CO donor infusion did not change the baseline RSNA in sham rabbits but decreased RSNA in CHF rabbits (Table 2 ).
The infusion of SNAP (1.2 <g/kg/min) caused a decrease in MAP and an increase in HR and RSNA in sham and CHF rabbits. Phenylephrine (0.2 to 1.0 <g/kg/min) returned MAP and HR to control levels in sham and CHF rabbits. After MAP stabilization, the baseline RSNA in sham rabbits was returned to control level, but the baseline RSNA in CHF rabbits remained decreased below control (Table 3) . Intravenous administration of LNNA (30 mg/kg) increased MAP and lowered HR and RSNA in sham and CHF rabbits. Hydralazine (0.01 to 0.06 mg/kg/min, i.v.) returned MAP and HR to control levels. After MAP stabilization, the baseline RSNA returned to control level in CHF rabbits but remained above control in sham rabbits.
( Table 3) .
Effect of NO donor and NOS inhibitor on the peripheral chemoreflex in sham and CHF rabbits:
We observed that baseline RSNA (normoxia) and the response of RSNA to hypoxia was enhanced in CHF rabbits compared with that in sham rabbits ( Fig.1-3) , which is consistent with that in our previous studies (10; 12; 28).
In sham rabbits, intravenous SNAP (1.2 <g/kg/min) did not affect either the baseline RSNA at normoxia or response of RSNA to graded hypoxia with MAP held at the control level by phenylephrine infusion (Fig 1, left top panel) ; L-NNA increased RSNA at normoxia and enhanced the responses of RSNA to isocapnic hypoxia with MAP held constant by hydralazine infusion (Fig. 1, left bottom panel) .
In CHF rabbits (Fig. 1, right panels) , L-NNA did not change either the baseline RSNA or response of RSNA to hypoxia while maintaining control MAP. However, NO donor SNAP markedly decreased the RSNA responses to hypoxia in CHF rabbits at constant MAP.
Effect of CO donor and HO blocker on the peripheral chemoreflex in sham and CHF rabbits:
In sham rabbits, intravenous infusion of [Ru(CO) 3 Cl 2 ] 2 (3.0 <g/kg/min) did not affect RSNA at normoxia or in response to isocapnic hypoxia at constant MAP (Fig. 2, left top panel) .
CrMP increased RSNA at normoxia and enhanced the responses of RSNA to isocapnic hypoxia (Fig. 2, left bottom panel) .
In CHF rabbits, the same dose of [Ru(CO) 3 Cl 2 ] 2 significantly reduced RSNA at normoxia and attenuated response to isocapnic hypoxia in CHF rabbits at constant MAP (Fig 2, right top panel). CrMP did not change RNSA at normoxia (baseline) or in response to isocapnic hypoxia in CHF rabbits (Fig 2, right bottom panel) .
Effect of CO donor plus NO donor and HO inhibitor plus NOS inhibitor on the
peripheral chemoreflex in sham and CHF rabbits CO donor [Ru(CO) 3 Cl 2 ] 2 plus NO donor SNAP showed no effect on RSNA during normoxia and the response of RSNA to isocapnic hypoxia in the sham rabbits at constant MAP ( 
Comparison of NO and CO pathway in the peripheral chemoreflex in sham and CHF
rabbits In sham rabbits, HO inhibitor CrMP, NOS inhibitor L-NNA, and CrMP plus L-NNA all enhanced RSNA response to hypoxia compared with that before administration of the drugs respectively (P<0.05 in Fig 1, 2 and 3 , left bottom panels). But the magnitude of the increased RSNA response to hypoxia by CrMP plus LNNA was greater than that induced by CrMP or LNNA alone (Fig 4, top panel) (Fig. 4, bottom panel) .
Protein expression of HO-2 and NOS in CBs from sham and CHF rabbits Western blot
analysis showed that CHF markedly decreased the protein expression of endogenous HO-2 in the CBs, compared with that in sham rabbits (Fig 5 A & B) . We also found that distinct immunostaining of HO-2 was predominantly localized to the glomus cell clusters in CB tissue, and immunostaining for HO-2 was decreased in the CB glomus cells clusters from CHF rabbits vs. sham rabbits (Fig 5 C by example) . The protein expression of nNOS and eNOS also was lower in CBs from CHF rabbits vs. sham rabbits (Fig 6 A & 
DISCUSSION
The major findings in the present study are that pharmacological suppression of both CO and NO signaling pathways enhances CB chemoreflex sensitivity to hypoxia in a cumulative manner in normal rabbits. The CO and NO pathways appear to be endogenously suppressed in the CHF state, which contribute, in a similar collective manner, to the enhanced chemoreflex function observed in these animals. These alterations are consistent with the measured downregulation of HO-2, nNOS and eNOS in the CBs from rabbits in the CHF state.
Studies from our laboratory have documented that peripheral chemoreflex sensitivity is increased in conscious rabbits with pacing-induced CHF, compared with that in sham rabbits (10; 12; 28). As rabbits lack functional aortic chemoreceptors, the peripheral chemoreflex is attributable mainly to the CBs in this species (3; 33). We have shown previously that inhibition of the CB reduces RSNA in CHF rabbits under normoxic conditions (28) . These results support the notion that enhanced basal activity from the CB chemoreceptors contributes to the sympathetic activation seen in CHF.
Although there are numerous factors that may affect peripheral chemoreceptor function, NO is thought to play an important role in this alteration. We previously documented that a decrease of NO production in the CBs contributes to an exaggerated CB chemoreceptor activity and CB function in CHF rabbits (10; 27), but we have not before investigated the effects of NO compared to CO on the functional chemoreflex in conscious rabbits. The two constitutive isomers of NOS, neural (nNOS or NOS-1) and endothelial (eNOS or NOS-3), are normally abundant in the CB (19; 23) , as illustrated in the present immunohistochemical analysis of the CB in normal rabbits. The present findings of enhanced chemoreflex function with NOS inhibition in normal rabbits and with decreased nNOS expression in the CB in the CHF condition are consistent with that as we have described in previous studies (10; 11; 27). Kline et al.
observed that mice deficient in nNOS showed greater chemoreflex responses to hypoxia than wild-type mice (9). We have confirmed the adenoviral transfer of nNOS gene to CB elevates nNOS protein expression and NO production of CHF rabbits to levels found in sham rabbits and reverses the enhanced chemoreceptor function in CHF rabbits (10). The specific nNOS inhibitor, S-methyl-L-thiocitrulline (SMTC), enhanced CB chemoreceptor activity in sham rabbits and failed to increase CB chemoreceptor activity in CHF rabbits (10). These results, taken together, demonstrate that a marked down regulation of endogenous nNOS in the CB plays an important role in the enhanced CB chemoreflex in CHF rabbits.
A downregulation of eNOS, as well as nNOS, was also found in the CB of CHF rabbits.
Decreased eNOS along with decreased nNOS is likely to exacerbate depletion of functional NO
in the CB and contribute to enhancement of the CB chemoreflex in CHF (31) . Suppression of eNOS expression in the CB raises an intriguing but unresolved question whether changes in CB microvascular function contribute to altered chemoreceptor sensitivity in CHF.
CO is also known to be an important signaling molecule in the CB (19; 20; 22) . The present study documents for the first time that CO, like NO, plays a functional role to restrain hypoxic sensitivity of the CB in normal conscious rabbit, and a CO deficiency in the CB contributes to enhanced peripheral chemoreflex function and sympathetic activation observed in CHF. At least 3 isoforms of HO have been identified: an inducible HO-1, and the constitutive HO-2 and HO-3 isoforms (15; 22); but HO-2 is highly and constitutively expressed in neuronal and chemosensing tissues, including CB glomus cells, whereas HO-1 is not (19; 35) . Several studies have assessed the functional significance of HO-2 in the CB (19; 20; 22) . Znprotoporphyrin-9, another inhibitor of HO, augments the CB sensory discharge in vitro, and exogenous administration of CO can reverse the augmentation of sensory discharge induced by Zn-protoporphyrin-9 (20). In the anesthetized rat, HO inhibition enhances respiratory responses to hypoxia but not to CO 2; and the site of action is on CB since the effects of HO inhibition are abolished by bilateral sections of carotid sinus nerves (19) . Similarly, using mutant mice lacking HO-2 isoform, the respiratory responses to hypoxia are greater than wild type mice (19) . These data strongly support our notion that an attenuated HO-2 activity in the CB of CHF rabbits contributes to the enhanced peripheral reflex response to hypoxia in this condition.
Williams et al. suggest HO-2 functions as an oxygen sensor by regulating K + channel activity during oxygen deprivation in CB cells, primarily through the production of CO (35).
However, we observed that pharmacological inhibition of CO production enhances rather than abolishes or suppresses chemoreflex responsiveness to hypoxia. Thus, it seems that in the rabbit at least, CO like NO serves as a modulator of afferent activity rather than as a mediator of O 2 sensing. Our present results also show that HO-2 protein expression is markedly decreased in the CB glomus cell cluster while reflex responses to hypoxia are enhanced in CHF rabbits compared with that in sham rabbits. Enhanced sensitivity to hypoxia in the setting of downregulation of HO-2 would be inconsistent with HO-2 serving as a primary O 2 sensor.
Our experiments further document a functional interaction between CO and NO pathways in the RSNA response to hypoxia. Co-administration of CO and NO donors blunted the exaggerated hypoxia-induced chemoreflex responses in CHF rabbits to a greater extent than that of either donor alone. Conversely, in sham rabbits, HO plus NOS inhibition induced a greater enhancement of the RSNA activation to hypoxia than that by either inhibitor alone. Thus, the CO and NO pathways in the CB have cumulative effects to enhance peripheral chemoreflex function under normoxic and hypoxic conditions in pacing-induced CHF rabbits.
The commonality of the downstream signaling pathways for CO and NO synthesized in rabbit CB need to be further defined. Importantly, NO and CO share some common properties with molecular oxygen. First, they bind to heme with greater affinity than oxgen and are coupled to activation of heme containing proteins (19) . Second, recent studies have demonstrated that NO and CO are involved in regulating intracellular calcium concentration (19) and the calcium- However, further studies are needed to determine if CO shares a similar effect.
Limitations
Pharmacological manipulation in the whole animal does not allow one to easily define the target of the drug effects. In the present study, our aim was to demonstrate that both NO and CO play a functional role in CB chemoreflex sensitivity in the conscious rabbit and that these signaling pathways are altered in CHF. We are not able to define the specific locations in the reflex arc where these molecules are operating. However, CrMP does not cross the blood brain barrier in the rat (2) and L-NNA inhibition of NOS in the brain exhibits a delay of 30 minutes or more after systemic administration in cat, pig and dog (30) , which would suggest that the effect of these inhibitors to enhance chemoreflex control of RSNA as observed in the present study are not due to a central action. In addition, from companion studies in our lab in which we used the same rabbit model of pacing-induced CHF, we have shown an enhanced afferent input from CB chemoreceptors in the CHF state (10; 12; 27). Furthermore, the enhanced afferent input from the CB in CHF was shown to be mediated in part by a downregulation of nNOS in the CB (10). In the present study, we found that protein levels of HO-2 and eNOS, in addition to nNOS are depressed in the CB of CHF rabbits. From these results, we can infer that L-NNA, SNAP, CrMP and ([Ru(CO) 3 Cl 2 ] 2 act upon the chemoreflex, at least in part, via modulating CB chemoreceptor activity, but we can not completely exclude possible effects on central or efferent sympathetic neural sites.
Changes in arterial pressure due to the vasoactive effects of NO/CO or their inhibitors were minimized in the present study by i.v. infusion of hydralazine or phenylephrine in order to prevent confounding influences of the arterial baroreflex on RSNA. These agents, themselves, are not likely to have contributed to alterations in chemoreflex function observed in our experiments. First, qualitatively similar changes in chemoreflex effects on RSNA were observed in a few animals in which pressure was not controlled by infusion. Secondly, infusion of these drugs alone at dosages used in this study had no effect on RSNA responses to hypoxia in either sham or CHF rabbits.
Perspective
It is generally accepted that the CB chemoreflex plays a relatively minor role in the overall control of tonic sympathetic outflow under normal resting conditions. Consequently, the CB chemoreflex is often overlooked or dismissed as a contributing factor to altered sympathetic function in cardiovascular disease not associated with hypoxemia. We demonstrate from our present and previous results, that a marked increase in CB chemoreflex sensitivity occurs in CHF as a result of alterations in multiple signaling pathways in the CB and central autonomic sites (7; 10-12; 21; 23; 24). This shift in sensitivity enhances CB chemoreflex control of sympathetic outflow even under normoxic conditions in CHF (see Fig.3) (23; 28) . Thus, the concept of the CB chemoreflex as a 'hypoxia' reflex needs to be redefined to accommodate its enhanced functionality under more normoxic eucapnic conditions in cardiovascular diseases. This shift in functionality of the chemoreflex elucidates its significance to the development and progression of sympathetic dysfunction in CHF.
The present study is the first to demonstrate a role of CO in altered CB chemoreflex function in a disease state. Our results demonstrate a cooperative role of the endogenous CO and NO pathways in the tonic restraint of CB chemoreflex sensitivity and sympathetic outflow in normal rabbits. Co-suppression of endogenous CO and NO acts cumulatively to enhance peripheral chemoreflex function in CHF. This alteration contributes to the increased sympathetic outflow under normoxic and hypoxic conditions in this disease state. The significance of CO and CO/NO interactions in other neuronal mechanisms of integrative control of sympathetic outflow in health and disease deserves further study. Table 3 ). Values are mean ± SE. n, Number of animals. * p<0.05 vs. before drug administration. 
